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Abstract Cell-free protein synthesis protocols for
uniformly deuterated proteins typically yield low, non-
uniform deuteration levels. This paper introduces an E. coli
cell-extract, D-S30, which enables efficient production of
proteins with high deuteration levels for all non-labile
hydrogen atom positions. Potential applications of the new
protocol may include production of proteins with selective
isotope-labeling of selected amino acid residues on a per-
deuterated background for studies of enzyme active sites or
for ligand screening in drug discovery projects, as well as
the synthesis of perdeuterated polypeptides for NMR
spectroscopy with large supra-molecular structures. As an
illustration, it is demonstrated that the 800-kDa chapero-
nine GroEL synthesized with the D-S30 cell-free system
had a uniform deuteration level of about 95% and assem-
bled into its biologically active oligomeric form.
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Introduction
Cell-free protein synthesis is of special interest for the
preparation of protein samples with non-uniform isotope
labeling for NMR spectroscopy. In particular, it provides
for efficient incorporation of selectively labeled amino
acids into polypeptide chains in situations where in vivo
protein expression typically results in isotope scrambling
or isotope dilution (Kigawa et al. 1995; Ozawa et al. 2004;
Waugh 1996), and its use can extend to cytotoxic proteins,
such as proteases or apoptosis-related proteins (Adrain et
al. 2006). Systems based on E. coli or wheat germ cell
extracts in continuous exchange reaction chambers are
widely used, with yields of several milligrams of protein
per milliliter of reaction mixture (Klammt et al. 2004;
Spirin et al. 1988; Vinarov et al. 2004). These fundamental
procedures are increasingly being supplemented by
eukaryotic cell-free systems generated from insect cells
(Ezure et al. 2006; Katzen and Kudlicki 2006; Wakiyama
et al. 2006) or hybridoma cell-lines (Mikami et al. 2006),
which allow further studies of post- and co-translational
events such as N-myristoylation (Sakurai et al. 2006).
This paper addresses specific applications of in vitro
synthesis for the production of perdeuterated proteins.
Work on a perdeuterated background is of potential interest
for studies of protein functions using residue-selective
stable isotope labeling. Furthermore, although most of the
proteins produced so far with the aforementioned cell-free
expression protocols are small monomeric structures,
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in vitro expression with stereo-array isotope labeling
(SAIL; Kainosho et al. 2006; Sugimori et al. 2004) has
generated interest in cell-free production of larger proteins,
and it has been well documented that high levels of deu-
teration are indispensable for solution NMR studies of
polypeptides in structures of sizes above 40 kDa (LeMaster
1989; Pachter et al. 1992). With in vivo expression in
2H2O-based medium, perdeuterated proteins are, however,
usually obtained only after lengthy ‘‘training’’ of the cells,
albeit typically with significantly lower expression yields
than in H2O-based growth media. Therefore, we felt that it
is of interest to explore the use of cell-free synthesis also
for the production of perdeuterated proteins. In this study,
we describe a protocol that achieves this goal and dem-
onstrate its use with the synthesis of the 800-kDa E. coli
chaperonine GroEL, which is an oligomeric protein with 14
identical subunits (Xu et al. 1997).
Materials and methods
Preparation of S30 and D-S30 extract
For the preparation of S30 extract, the E. coli strain
BL21 Star (DE3; Invitrogen) was used, since the cell
extract from this strain showed a better performance than
the S30 extract obtained from regular BL21 (DE3) or
BL21 (DE3) RIL strains (Kigawa et al. 2004). The pro-
duction of S30 extract was based on previously reported
protocols (Kigawa et al. 2004; Torizawa et al. 2004),
with modifications that increased the efficiency of protein
synthesis. Thereby, 9 l of incomplete rich medium con-
taining 10 g/l of yeast extract, 1% w/v glucose, 40 mM
KH2PO4 and 165 mM K2HPO4 were inoculated with
40 ml of overnight culture. The cells were harvested at
an early phase of exponential growth (OD600 of 0.7), and
were then washed three times with 400 ml of ice-cold
S30 buffer (7 mM b-mercaptoethanol, 1 mM dithiothre-
itol, 14 mM magnesium acetate, 60 mM potassium
acetate, 10 mM Tris-acetate at pH 8.2). Cell-breakage
was carried out with a single passage of the cell sus-
pension (0.8 g/ml) in S30 buffer through a French-Press
at 15,000 psi, followed by two rounds of centrifugation
of the cell-lysate at 30,000 · g at 4C.
In order to increase the translation efficiency, the cell
extract thus obtained was supplemented with purified
ribosomes that had been isolated from 9 l of E. coli BL21
Star cell culture (DE3; Invitrogen) grown in incomplete
rich medium. Ribosome purification was based on ultra-
centrifugation (115,000 · g, 17 h at 4C) and a sucrose
cushion approach (Schaffitzel and Ban 2007). 50 mg of
purified ribosomes were thus obtained per liter of E. coli
cell culture.
For removal of the endogenous mRNAs and their trans-
lation products, 1 ml of freshly obtained cell-lysate was
incubated for 60 min at 25C with 155 ll of a solution
containing 13 mM ATP, 40 lM of each of the 20 protei-
nogenic amino acids, 4 mM DTT, 9 mM magnesium
acetate, 85 mM phosphoenolpyruvate, 20 units of pyruvate
kinase and 290 mM Tris-acetate at pH 8.2. After incubation,
the extract was dialyzed three times against 1 l of S30 buffer
at 4C, followed by an additional overnight dialysis against
2 l of S30 buffer at 4C using a Spectra/pore membrane with
a molecular weight cut off (MWCO) of 3,000 Da. These
extensive dialysis steps ensured complete removal of
endogenous amino acids from the cell extract. Using a
dialysis step against polyethylene glycol 8000 (PEG-8000)
in /S30 buffer (50% w/w), the final volume of the extract
obtained from 9 l of cell culture was reduced to 15 ml, and
after additional centrifugation for 10 min at 4,000 · g and
4C, the S30 extract was stored at –80C until further use.
For the preparation of D-S30 extract, 5 ml aliquots of
S30 extract were dialyzed against S30 buffer in 2H2O,
using a centrifugal filter device (MWCO 10,000 Da), and
the buffer exchange against an equal volume of deuterated
S30 buffer was repeated six times.
Expression and purification of T7 RNA polymerase
Expression and purification of T7 RNA polymerase was
based on using the pT7-911 vector, which is derived from
pQE-8 (Qiagen) encoding the T7 RNA polymerase
(RNAP) gene with a poly-His6 purification tag at the
N-terminus. RNAP was expressed in E. coli cells BL21
(DE3) (Stratagene), using a standard procedure with
induction of protein expression by the addition of 1 mM
isopropyl b-D-thiogalactopyranoside (IPTG). Cell breakage
was carried out by several passages through a French-Press
at 20,000 psi, and protein purification was carried out by
affinity chromatography using a Ni–NTA–agarose resin
column followed by size exclusion chromatography.
Cell-free protein synthesis
Analytical-scale cell-free synthesis of the FK 506-binding
protein (FKBP) and of GroEL was carried out in batch
mode. In order to optimize the reaction conditions of
temperature, salts and amino acid concentrations, the cell-
free reaction setup was first carried out using unlabeled
amino acids (Cambridge Isotope Laboratories, Inc., CIL).
The optimized conditions were then used for preparative-
scale synthesis of U-2H, U-15N-labeled samples of FKBP
and GroEL, using a [U-2H 98%, U-15N 98%]- amino acid
mixture (CIL).
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The genes of FKBP and GroEL were cloned into the
cell-free vectors pIVEX 2.3d and pIVEX 2.4d (Roche).
Depending on the overall reaction yield and the isotope
consumption, the large-scale reaction was carried out either
in the batch mode or by continuous-exchange cell-free
(CECF) protein synthesis. The nutrient compositions used
for the batch and CECF modes are given in Table 1. The
ratio of reaction volume and feeding volume in the CECF
setup was 10:1. For the production of deuterated proteins,
all the substrates for the cell-free protein synthesis reaction
were prepared in 2H2O. In order to remove residual water
prior to the preparation of the substrates in 2H2O, the stable
salts (Table 1) were heated at 200C for 2 h before they
were dissolved in 2H2O. The reaction mixture was incu-
bated at 30C and 450 rpm either for 5 h (batch mode), or
for 17 h (CECF mode), using a tabletop thermomixer
(Eppendorff).
Protein purification
Purification of FKBP was based on affinity chromatogra-
phy using a Ni–NTA–agarose resin column and a linear
gradient of imidazole. After the cell-free reaction, the
reaction and feeding volumes were collected and
centrifuged for 10 min at 15,000 g. The supernatant was
loaded on the Ni–NTA–agarose resin column equilibrated
with buffer A (30 mM imidazole, 500 mM NaCl, 20 mM
sodium phosphate, pH 7.2) and the column was washed
with three volumes of this buffer. FKBP was eluted from
the column with a linear gradient of imidazole (0-500 mM,
5 column volumes) in buffer A, together with RNAP. An
additional size exclusion chromatography was carried out
to separate RNAP from FKBP, using a Superdex 75 prep
grade column (GE Healthcare) equilibrated in NMR buffer
(20 mM sodium phosphate, pH 6.2). The fractions con-
taining FKBP were pooled and concentrated to a final
volume of 500 ll. Typically; protein concentrations of
about 500 lM (5 mg of protein) were obtained from a 4 ml
CECF protein synthesis reaction.
For the purpose of comparative studies, we also pre-
pared in vivo deuterated GroEL, based on previously
reported isolation methods (Fiaux et al. 2002; Xu et al.
1997). Cells carrying a plasmid for GroEL overexpression
were grown under ampicillin control in 2H2O -based min-
imal medium, and overexpression was induced with IPTG.
2–3 g of harvested cells were resuspended in 30 ml of
extraction buffer (100 mM TrisCl, 1mM DTT, 0.1 mg/ml
DNase I, pH 8.0) and lysed by sonication followed by
centrifugation for 30 min at 30,000 · g and 4C. At this
point, only a single step of ammonium sulphate precipita-
tion (40% w/v) was carried out, and after another
centrifugation step the supernatant was applied to a High-
Prep 26/10 desalting column (GE Healthcare). This was
followed by anion exchange chromatography using a
DEAE-Sepharose fast flow column equilibrated in buffer B
(50 mM TrisCl, 2 mM DTT, pH 7.2). Prior to elution, the
column was washed with three column volumes of buffer
B, and GroEL was eluted using a linear gradient of NaCl
(0–500 mM, 5 column volumes) in buffer B. The fractions
containing GroEL were concentrated and loaded on a Su-
perdex 200 prep grade column equilibrated with NMR
buffer (25 mM potassium phosphate, 20 mM KCl, pH 6.2).
For in vitro synthesized GroEL, the ammonium sulphate
precipitation step was omitted. Although similar elution
profiles from the gel filtration column were observed for
in vivo and in vitro produced GroEL, insoluble aggregates
were immediately formed upon addition of 40% w/v
ammonium sulphate to the in vitro reaction mixture.
Therefore, an additional anion exchange chromatography
step was carried out after the initial DEAE-Sepharose fast
flow column and the following desalting step, using a high
resolution Resource Q column (GE Healthcare) equili-
brated in buffer B. GroEL was eluted from the column
using a linear gradient of NaCl (0–500 mM, 10 column
volumes). Finally, fractions containing GroEL were con-
centrated and subjected to size exclusion chromatography,
as described for the in vivo expressed GroEL.
Table 1 Composition of the reaction mixture (1 ml) and the feeding
mixture (10 ml) used for CECF protein synthesisa
Components Reaction mixture Feeding mixture
S30-extract (OD280, 200) 330 ll –
Plasmid DNA 10 lg/ml –
T7-RNA polymerase 170 lg/ml –
E. coli tRNA 240 lg/ml 66 lg/ml
Mixture of 20 amino acids 1.5 mM (each) 1.5 mM (each)
Creatine kinase 83 lg/ml –
Phosphocreatine 84 mM 84 mM
ATP 1.27 mM 1.27 mM
CTP, GTP, UTP 0.9 mM (each) 0.9 mM (each)
cAMP 0.67 mM 0.67 mM
Folinic acid 36 lg/ml 36 lg/ml
DTT 2.1 mM 2.1 mM
Tris-acetate, pH 8.2 3 mM 3 mM
Hepes-KOH, pH 7.5 60 mM 60 mM
Ammonium acetate 29 mM 29 mM
Magnesium acetate 11.2 mM 11.2 mM
Potassium acetate 20 mM 20 mM
Potassium glutamate 210 mM 210 mM
Polyethyleneglycol 8000 4% (w/v) 4% (w/v)
Sodium azide 0.025% (w/v) 0.025% (w/v)
a In the batch setup, the reaction was carried out in the reaction
mixture for 4–5 h at 30C and 450 rpm
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Collection of NMR data
All NMR experiments with FKBP were recorded at 25C
on a Bruker DRX600 spectrometer equipped with a stan-
dard triple resonance probehead. The protein concentration
was adjusted to 0.8 mM. For the 3D 15N-resolved [1H,1H]-
TOCSY experiment with a mixing time of sm = 60 ms,
eight transients were added with an interscan delay of 1 s,
resulting in a total measurement time of 39 h. 1024 com-
plex points were recorded with an acquisition time of
131 ms, and prior to Fourier transformation the FID was
multiplied with a 75-shifted sine bell and zero-filled to
2048 complex points. In the x1(
1H)-dimension, 95 com-
plex points were measured, with a maximal evolution time
of 12 ms, and the data was multiplied with a 75-shifted
sine bell (De Marco and Wu¨thrich 1976) and zero-filled to
256 complex points before Fourier transformation. In the x
2(
15N)-dimension, 42 complex points were measured, with
a maximal evolution time of 21 ms, and the data was
multiplied with a 75-shifted sine bell and zero-filled to
128 complex points before Fourier transformation. For the
2D [1H,1H]-NOESY experiments with a mixing time of
sm = 100 ms, 128 transients were added with an interscan
delay of 1 s, resulting in a total measurement time of 20 h.
About Thousand and twenty four complex points were
recorded with an acquisition time of 128 ms, and prior to
Fourier transformation the FID was multiplied with a 75-
shifted sine bell and zero-filled to 2048 complex points. In
the x1(
1H)-dimension, 256 complex points were measured,
with a maximal evolution time of 32 ms, and the data was
multiplied with a cosine function and zero-filled to 512
complex points before Fourier transformation.
For GroEL produced by cell-free expression, a 2D
[15N,1H]-CRIPT-TROSY spectrum was recorded at 35C
on a Bruker Avance900 spectrometer equipped with a
standard triple resonance probehead. The protein concen-
tration was 0.7 mM in monomers, and the transfer time
was T = 1.4 ms (Fiaux et al. 2002). 4048 transients were
added with an interscan delay of 300 ms, resulting in a
total measurement time of 4 days. In the x2 (
1H)-dimen-
sion, 1024 complex points were recorded with an
acquisition time of 81 ms. Prior to Fourier transformation
the FID was multiplied with a cosine function and zero-
filled to 2048 complex points. In the x1 (
15N)-dimension,
100 complex points were measured, with a maximal evo-
lution time of 20 ms, and prior to Fourier transformation
the data was multiplied with a 20-shifted sine bell and
zero-filled to 256 complex points.
For GroEL prepared in vivo, a 2D [15N,1H]-CRIPT-
TROSY experiment was recorded with the same conditions
as for the cell-free preparation, except for the following:
the experiment was recorded on a DRX750 spectrometer,
the protein concentration was 1.9 mM in monomers, 512
transients were added, the acquisition time was 97 ms, in
the x1 (
15N)-dimension the maximal evolution time was
22 ms, and the total measurement time was 12 h.
In all experiments, the baseline was corrected using the
IFLAT method (Bartels et al. 1995) in the direct dimen-
sion, and with polynomials of 2nd order in the indirect
dimension.
Results and discussion
Cell-free expression of GroEL in H2O-based growth
medium
Cell-free synthesis of GroEL was carried out using the
batch mode approach, which is cost-effective for the
expression of large amounts of protein due to the low
amount of amino acids needed (Table 1). This is an
important aspect, since about 30 mg of protein are required
for an NMR sample with a GroEL concentration of 1 mM
in monomers. About 400 lg of GroEL were produced from
1 ml of reaction mixture (Fig. 1a and b), of which about
55% were accessible in soluble form, as shown by ana-
lytical ultra-centrifugation. The formation of the native
multimeric form was confirmed by analytical size exclu-
sion chromatography (Fig. 1c), which showed that the
retention time and the elution profiles were almost identical
to those of in vivo expressed GroEL.
Attempts to produce perdeuterated proteins using H2O-
based S30 extract
As a first approach to cell-free production of perdeuterated
proteins, the standard cell-free protein synthesis protocol
(Torizawa et al. 2004) was applied, using a mixture of the
20 proteinogenic amino acids with U-98% deuteration as
the amino acid source (Table 1). The relative expression
level with the deuterated amino acids was about 95% of the
yield in cell-free synthesis of GroEL using unlabeled
amino acids. However, mass spectroscopy of the protein
showed a 0.5% smaller mass than expected for the fully
perdeuterated protein, which could have been due to the
incorporation of non-labeled amino acids present in the
S30 extract. To eliminate this potential source of unlabeled
amino acids, the protocol used for the preparation of S30
extract was supplemented with an additional size exclusion
chromatography step (Torizawa et al. 2004). Absence of
residual amino acids in the resulting S30 extract was
confirmed by the observation that immune-blotting assays
for protein synthesis in reaction mixtures without amino
acid supplementation did not show any detectable bands of
newly synthesized protein. Nonetheless, the deuteration
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level of the protein expressed with perdeuterated amino
acids did not increase significantly. 1D 1H-NMR spectra of
a sample of 31 mg of deuterated GroEL prepared in a
100 ml reaction volume using the batch mode indicated a
high degree of back-protonation at Ha- positions, and to a
lesser extent also at Hb- positions. In contrast, the high-
field region of the 1H NMR spectrum showed a deuteration
level of about 95% for the methyl groups of the protein
(data not shown).
At this point we turned to the 110-residue FK506
binding protein (FKBP) for more detailed investigations of
the a- and b-protonation levels in proteins from cell-free
production with perdeuterated amino acids, since for FKBP
the chemical shift assignments are known (Rosen et al.
1991; Xu et al. 1993). A reaction volume of 4 ml in a
CECF setup produced 6.3 mg of FKBP, resulting in a
1.1 mM NMR sample. NMR experiments confirmed the
observation of partial back-protonation at the a- and
b-positions (Fig. 2), showing that it is exchange of Ha and
H b with bulk water during the cell-free polypeptide syn-
thesis system that prevents perdeuteration of the protein.
Cell-free synthesis of several other soluble and membrane
proteins in both batch and CECF setups yielded similar
results to those with FKBP. Semi-quantitative analysis of
2D [1H,1H]-NOESY and 3D 15N-resolved [1H,1H]-TOCSY
spectra recorded with FKBP further revealed that the back-
exchange is amino acid-specific, and that the 20 amino
acids can be classified in four groups with different relative
back-protonation levels (Table 2). At the a-position, Asp,
Asn, Glu and Gln show high back-protonation, Gly, Ser,
Cys, Ala, Phe, Trp and Tyr are a second group with
intermediate back-protonation, Val, Ile, Leu Lys and Arg
have a low degree of back-protonation, and Thr, His and
Met show almost no back-protonation. At the b-position,
Asp, Asn, Gln and Glu have high back-protonation, Ala,
Phe and Tyr show low b back-protonation (Fig. 2), and no
back-protonation was detected for the other amino acids
with the presently used methods.
Preparation of deuterated S30 extract (D-S30) for cell-
free synthesis
In cell-free synthesis with the batch setup, 33% of the
reaction volume is comprised of S30 extract, which was
thus a prime target for modifications aimed at reduced
back-protonation. In principle, deuterated S30 extract
could be obtained from cells grown in 2H2O-based med-
ium. However, since the harsh growth conditions in 2H2O
reduce the overall fitness of bacterial cells, we would
expect the activity of such cell-extract to be reduced.
Further, since about 18 l of 2H2O would be needed for
obtaining 15 ml of cell-extract, this approach would not be
cost-effective. We therefore chose the alternative of
exchanging 2H2O into S30 extract that had been prepared
on a H2O-basis, either by filtration, dialysis or
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Fig. 1 Cell-free protein synthesis of GroEL and FKBP at natural
isotope distribution. (a) Translation efficiency of cell-free protein
synthesis monitored by SDS-Page. Lanes: 1, FKBP using CECF protein
synthesis, the yield is 1.5 mg/ml reaction mixture; 2, negative control;
3, GroEL synthesized by batch mode cell-free proteins synthesis, the
yield is 300 lg/ml reaction mixture; 4, protein ladder with indication of
molecular weights in kDa. (b) Anion exchange chromatography for the
purification of cell-free synthesized GroEL. The protein elutes as a
single peak, identified by an arrow. (c) Analytical size exclusion
chromatography of GroEL. The elution volume of 10.4 ml corresponds
to a particle size larger than 400 kDa (column specification)
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lyophilization. In all assays, the activity of the resulting
2H2O–S30 extract was compared to the activity of standard
S30 extract.
High activity of the cell extract in 2H2O with reasonable
buffer exchange costs was achieved using an optimized
filtration procedure. In a series of assays, H2O was replaced
by 2H2O using different filtration devices covering
molecular weight cutoffs (MWCO) between 3,000 and
50,000 Da. The resulting extracts were evaluated by their
protein synthesis efficiencies as monitored by Western
blotting. Optimal synthesis efficiency was obtained with a
MWCO of 10,000 Da. MWCO values below 10,000
resulted in the formation of larger amounts of precipitates,
which could not be resuspended, and MWCO values above
10,000 resulted in reduced extract activity. The maximal
translation efficiency of the D-S30 extract was about 65%
of that of the conventional S30 extract. For preparative-
scale production of D-S30 cell extract we used six filtration
cycles with a dilution factor of 2, resulting in a 2H2O level
above 98%. A higher number of filtration cycles resulted in
reduced translation efficiency of the D-S30 extract. In spite
of inevitable residual H2O content in the other components
of the cell-free reaction setup (Table 1), the final H2O
concentration in the D-S30-based reaction mixture was less
than 5%.
Comparable results to those from the adopted filtration
procedure were achieved with conventional dialysis,
resulting in 60–70% of the activity of S30 extract, but due
to the large volume of 2H2O needed for complete buffer
exchange, this approach is economically not viable.
Lyophilization turned out to be inadequate, since only
partial resuspension of the lyophilized extract was
achieved, with nearly zero remaining activity of the cell-
extract. This is probably due to the fact that several steps of
freezing followed by lyophilization of cell-extract are
required to remove residual water, and each lyophilization
had to be carried out for several hours.
The D-S30 extract was supplemented with purified
ribosomes prior to the final filtration step, which further
increased the overall efficiency of the synthesis reaction to
about 85% of the efficiency of the conventional S30 extract
without ribosome supplementation (see Material and
methods).
Comparison of deuteration levels obtained with S30
and D-S30 extract
The Figs. 3 and 4 show comparisons of 2D [1H,1H]-NO-
ESY data of FKBP produced in vitro using either the
conventional S30-extract or the new D-S30 extract. All the
spectra were recorded on a 600 MHz spectrometer with a
mixing time of 100 ms, and processed identically. The
protein concentration was adjusted to 800 lM as
determined by UV absorption spectra. The high level of
back-protonation in the protein prepared with conventional
S30-extract is manifested by the appearance of numerous
HN–Ha and HN–Hb cross peaks (Figs. 3 and 4b). Most of
the HN-Ha cross-peaks in Fig. 4b originate from Asp
(Fig. 3a), Asn, Glu and Gln residues, which also show a
high tendency for back-protonation in the b-positions. In
addition, the back-protonation of the Ala methyls is rather
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Fig. 2 Observation of back-protonation during the incorporation of
perdeuterated amino acids by cell-free protein synthesis of FKBP in
H2O-based reaction mixture monitored with 3D
15N resolved [1H,1H]-
TOCSY experiments (sm = 60 ms). Data are shown for six residues,
where the HN–N–HN cross peaks are black (these serve as a reference
with relative intensity corresponding to 100% occupancy of the two
correlated proton sites), the HN–N–Ha peaks are blue, and the HN–N–
Hb peaks red. The intensities of the blue and red peaks manifest the
extent of back-protonation at the Ha and Hb sites, respectively. The
NMR data were processed with the software PROSA (Gu¨ntert et al.
1992)
Table 2 Amino acid-dependent back-protonation at the a- and
b-positions during cell-free protein synthesis using perdeuterated
amino acids in H2O-based culture medium
Amino acids Relative degree of a- and
b -back-protonationa
Asp, Asn, Gln, Glu Very high
Ala, Cys, Gly, Phe, Ser, Trp, Tyr High
Arg, Ile, Leu, Lys, Val Medium
Thr, His, Met Low
a The classification is based on semi-quantitative analysis of 3D
15N-resolved [1H,1H]-TOCSY and 2D [1H,1H]-NOESY spectra
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striking (Fig. 3b). The reduced back-protonation in the
FKBP preparation from the D-S30 extract is reflected by
the dramatically reduced peak intensities in the cross
sections of Fig. 3. In Fig. 4a the spectral region [x1 =
x2 = 6.0–10.3 ppm], which contains amide proton-amide
proton cross peaks, is identical to Fig. 4b, whereas the
10.0
Hα Ala 72  Hβ Ala 72
Hα Asp 41
Hβ Asp 41
ω2(1H) [ppm]
a
b
8.0 4.0 2.0
Fig. 3 Amino acid-specific
back-protonation monitored by
comparison of 1D cross-sections
taken from 2D [1H,1H]-NOESY
experiments recorded with
FKBP at 600 MHz with a
mixing time of 100 ms. (a) Asp
41. (b) Ala 72. Color code:
black, sample prepared in H2O-
based S30 cell extract; cyan,
synthesis in D-S30 cell extract.
In both experiments, U-2H 98%,
U-15N 98% amino acids were
used in the reaction mixture
8.010.0
2.0
4.0
6.0
8.0
10.0
8.010.0 ω2(1H) [ppm]
ω1(1H)
[ppm]
a b 
Fig. 4 Back-protonation of
perdeuterated amino acids
during in vitro synthesis of
FKBP monitored by comparison
of the 600 MHz 2D [1H,1H]-
NOESY spectra of FKBP
produced in vitro using either
D-S30 cell extract (a) or H2O-
based S30-extract (b). The
protein concentration was
800 lM in both samples, the
measurements were carried out
at 23C with a mixing time of
100 ms, and the two spectra
were recorded and processed
identically
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much lower population of HN–Ha and HN-Hb cross peaks
in the remainder of the spectrum is readily apparent. There
is some residual back-protonation at the b-positions of Asp
(Fig. 3a) and Asn, but this is also much lower than with the
conventional S30 extract.
GroEL synthesis with D-S30 extract
The translation efficiency of the new D-S30 extract for the
synthesis of GroEL with unlabeled or with perdeuterated
amino acids was similar. The elution profiles were similar
to those shown in Fig. 1 for protonated GroEL. A MS
analysis of GroEL synthesized from deuterated amino
acids in D-S30 extract showed a deuteration level of about
95%. 2D [15N,1H]-CRIPT-TROSY spectra of GroEL syn-
thesized with the D-S30 extract and of GroEL prepared by
in vivo protein expression show high similarity of the two
samples (Fig. 5), indicating that proper assembly of the
cell-free synthesized GroEL monomers into the biologi-
cally active 14-mer was achieved.
An observation of potential biological interest resulted
for the peaks contained in the red boxes of Fig. 5b, which
have higher intensity than the signals at the same chemical
shifts in the in vivo produced GroEL (Fig. 5a). To follow
this up, we used the same gene construct of GroEL in the
pIVEX 2.3d vector for both in vivo expression and
cell-free synthesis of unlabeled GroEL. MALDI mass
spectroscopy of the purified protein samples indicated that
the mass of the in vitro synthesized GroEL is 116 Da
higher than that of the in vivo expressed protein. The ter-
minal residue in the GroEL sequence is methionine, and
cleavage of this residue would give a mass reduction by
131 Da. Since the deviation of the molecular mass differ-
ence of 15 Da is within the expected error range
of ± 20 Da, we speculate that the absence of the terminal
Met in the in vivo produced GroEL results in reduced
flexibility of the C-terminal polypeptide segment and
concomitant line-broadening of the NMR signals.
Conclusions
The presently described protocol for cell-free synthesis of
perdeuterated proteins based on the use of deuterated
D-S30 cell extract yields 95% deuteration of the non-labile
proton positions, with similar expression levels as the
H2O-based S30 cell extract. With this approach, in vitro
synthesis of perdeuterated proteins should thus be eco-
nomically viable. In addition to the production of
perdeuterated proteins, the protocol may be adaptable for
more sophisticated isotope labeling schemes, which are not
readily accessible by other techniques. For example,
selective incorporation of individual 1H, 13C ,15N-labeled
110
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Fig. 5 2D [15N,1H]-CRIPT-TROSY NMR spectra (Fiaux et al. 2002;
Riek et al. 2002) of two different samples of uniformly 2H,15N-
labelled GroEL. (a) Protein expressed in vivo in E. coli cells. (b)
Protein synthesized in vitro with D-S30 extract. Two spectral regions
highlighted in spectrum (b) by red rectangles identify local differ-
ences between the two spectra that are discussed in the text
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amino acid types into proteins on a uniform 2H, 12C,
14N-background could open new perspectives for active
site screening of enzymes and receptor proteins, with
practical applications in drug discovery and drug design
projects. The approach used here with E. coli cell extract
should in principle also be applicable with other cell-free
systems, for example, with wheat germ or insect cell
extract for the production of eukaryotic proteins.
As mentioned above, the ability to produce proteins with
uniform high-level deuteration of all non-labile and labile
hydrogen positions is of interest for many potential appli-
cations. A limitation of the D-S30-based in vitro
expression system is that it cannot yield selective deuter-
ation of only the non-labile protons. This type of deuterium
labeling would be of interest in all situations where part of
the labile proton positions cannot be exchanged with the
solvent when dissolving the perdeuterated protein in H2O
(Wu¨thrich 1986). Our studies of back-protonation of deu-
terated amino acids during cell-free synthesis in H2O-based
cell extract (Figs. 2–4) may, however, provide a starting
platform for the future design of protocols enabling in vitro
synthesis of proteins with selective deuteration of only the
non-labile proton positions. In particular, an indication that
back-protonation could be due to amino acid type-specific
enzymatic reactions in the cell extract comes from the
observations that strong back-protonation at the a-position
is observed only for some of the amino acids (Table 2) and
that back-protonation at the b-position is even more
selective. In designing an exploratory experiment, we
hypothesized that racemase activities could be a cause for
the amino acid-dependent back-protonation and screened
the cell-extract for racemase activities. Thereby we made
use of the fact that D-glutamate and D-aspartate are
important components of peptidogylcan synthesis in bac-
terial cell-wall biosynthesis (Sengupta et al. 2006; Veiga
et al. 2006), where D-Glu and D-Asp are synthesized from
L-Glu and L-Asp, respectively, by specific glutamate- and
aspartate-racemases. To make use of the reverse reactions,
we added D-Glu and D-Asp instead of their L-counterparts
to the cell-free protein synthesis setup, and the amount of
protein produced with this variant amino acid mixture was
monitored by an immunoassay using anti-His antibodies.
These experiments did not yield any significant protein
production, showing that there is at most low glutamate-
and aspartate-racemase activity, and indicating that other
factors than racemase activities in the cell-extract might
have a dominant role in the observed back-protonation.
Considering that E. coli crude cell extract has a very
complex composition, exhaustive elimination of all
potential causes for the observed back-protonation might
turn out to be a laborious project. As an alternative, one
might want to consider the use of the ‘‘Pure Translation
System’’ (Shimizu et al. 2005), which is comprised
exclusively of components that are required for protein
translation. In spite of the as yet low reaction yields of the
‘‘Pure Translation System’’, analytical-scale studies with
this system might help to gain further insight into the
causes of back-protonation.
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